Vanda Pharmaceuticals (VNDA) Receivables - Other (2011 - 2014)

Vanda Pharmaceuticals' Receivables - Other history runs 4 years deep, the most recent figure standing at $1.6 million for Q4 2014.

• In Q4 2014, Receivables - Other fell 20.0% year-over-year to $1.6 million; the TTM figure through Dec 2014 stood at $1.6 million (down 20.0% YoY), while the FY2014 annual figure was $1.6 million, down 20.0% from the prior year.
• Receivables - Other came in at $1.6 million for Q4 2014 at Vanda Pharmaceuticals, down from $2.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $2.0 million in Q4 2013 to a low of $21000.0 in Q3 2012.
• A 4-year average of $752600.0 and a median of $116000.0 in 2011 frame the typical range for Receivables - Other.
• On a YoY basis, Receivables - Other climbed as much as 20.0% in 2014 and fell as far as 20.0% in 2014.
• Vanda Pharmaceuticals' Receivables - Other stood at $116000.0 in 2011, then sank by 81.9% to $21000.0 in 2012, then soared by 9423.81% to $2.0 million in 2013, then decreased by 20.0% to $1.6 million in 2014.
• According to Business Quant data, Receivables - Other over the past three periods registered $1.6 million, $2.0 million, and $21000.0 for Q4 2014, Q4 2013, and Q3 2012 respectively.

Peer Comparison